Skip to content

Clinical study of music therapy in patients with lung cancer complicated with anxiety

Clinical study of music therapy in patients with lung cancer complicated with anxiety

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037317
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Lung malignancy has been histopathologically or cytologically confirmed, and anxiety related to cancer treatment or cancer itself is >= 2 months and = 7 and <= 56; PS 0-1 points; 3. Ages 18-74, BMI between 18.5 and 23.9; 4. No history of chronic gastrointestinal diseases;No history of gastrointestinal surgery;No history of other mental illness; Did not take psychiatric drugs;No bad habits such as tobacco and alcohol; 5. Clear consciousness, normal behavior and hearing, no professional music background;Heart, liver, kidney, blood tests and other indicators are within the normal range; 6. No anti-anxiety drugs, antibiotics, non-steroidal drugs, microecological agents, gastrointestinal motional drugs, etc., were used in the past 4 weeks; 7. Regular three meals within the last 4 weeks, with meat and vegetable matching, no overeating, and control caffeine intake; 8. The expected survival time is more than 6 months; 9. Those who agree to participate in the study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Participating in other clinical studies or clinical trials; 2. Patients with other serious diseases, such as infection, liver and kidney failure, who are considered by the project leader or researchers to be unable to tolerate the treatment regimen of this study; 3. Primary or metastatic brain tumors confirmed clinically or radiologically; 4. Pregnant or lactating women; 5. Participants received music therapy within 3 months prior to study; 6. Taking other anxiety medications or medications that affect anxiety.

Design outcomes

Primary

MeasureTime frame
State-Trait Anxiety Inventory;Distend Thermometer;Hamilton Anxiety Scale;

Secondary

MeasureTime frame
the EORTC Quality of Life Questionnaire-Core 30, EORTC QLQ-C30;Interleukin;5-HT;Fecal intestinal flora;

Countries

China

Contacts

Public ContactSun Chenbing

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

greatbingbing@163.com+86 18817339858

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026